Table I.
Log FC | |||
---|---|---|---|
Gene name | GSE39001 | GSE9750 | GSE63514 |
CFD | 3.99 | 2.83 | 2.91 |
APOD | 3.76 | 2.55 | 3.53 |
CRNN | 3.36 | 8.07 | 9.51 |
CXCL14 | 3.22 | 2.27 | 3.77 |
MAL | 3.18 | 6.35 | 6.35 |
CRISP3 | 3.18 | 7.21 | 8.91 |
ESR1 | 3.10 | 3.15 | 4.12 |
CRCT1 | 3.02 | 5.54 | 5.34 |
DEFB1 | 2.79 | 1.70 | 2.68 |
SPINK5 | 2.78 | 4.98 | 5.85 |
NDN | 2.69 | 1.53 | 2.38 |
ID4 | 2.63 | 2.31 | 2.07 |
KRT13 | 2.61 | 4.50 | 4.67 |
ALOX12 | 2.50 | 5.56 | 5.27 |
SPRR3 | 2.50 | 4.64 | 5.56 |
PPP1R3C | 2.47 | 4.54 | 5.12 |
EDN3 | 2.36 | 5.13 | 5.40 |
MPPED2 | 2.31 | 1.51 | 3.19 |
FCGBP | 2.22 | 1.60 | 4.72 |
CYP2B6 | 2.08 | 1.73 | 2.63 |
NEK2 | −2.05 | −3.40 | −2.64 |
PLOD2 | −2.08 | −1.92 | −3.23 |
KIF20A | −2.10 | −1.78 | −2.09 |
CXCL9 | −2.12 | −1.50 | −3.71 |
CENPA | −2.13 | −1.77 | −2.70 |
AURKA | −2.18 | −2.41 | −2.52 |
CXCL10 | −2.20 | −1.34 | −2.97 |
APOBEC3B | −2.29 | −1.50 | −2.58 |
MCM2 | −2.39 | −2.33 | −2.61 |
SMC4 | −2.45 | −1.50 | −3.02 |
MMP1 | −2.46 | −5.49 | −2.82 |
CDK1 | −2.49 | −2.41 | −2.88 |
SYCP2 | −2.51 | −3.34 | −5.15 |
CDKN3 | −2.58 | −1.06 | −2.53 |
TOP2A | −2.60 | −2.24 | −2.53 |
CDKN2A | −2.61 | −3.78 | −6.41 |
RFC4 | −2.75 | −1.76 | −3.15 |
KRT17 | −2.80 | −1.95 | −2.63 |
UBD | −2.81 | −3.46 | −2.00 |
PRC1 | −2.86 | −1.65 | −2.25 |
TYMS | −3.22 | −2.03 | −2.09 |
MMP12 | −3.23 | −2.68 | −5.05 |
NUSAP1 | −3.35 | −1.73 | −2.36 |
RRM2 | −3.48 | −1.94 | −2.16 |
A positive log FC value indicates that the gene expression level was downregulated in the cervical cancer samples, whereas a negative log FC value indicates that the gene expression level was upregulated in the cervical cancer samples. Thresholds used in the GEO2R analysis were adjusted P<0.05, fold >2. Gene names were listed in line with the gene database at the national center for biological information. FC, fold-change.